Contact Us
Drug Search Results
More Filters [+]

Fursultiamine

Alternative Names: fursultiamine, adventan
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ThTR Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: China | Hong Kong | India | Indonesia | Korea | Malaysia | Pakistan | Portugal | Spain | Taiwan | United Arab Emirates | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Fundacion IMIM
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fursultiamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Esophageal Cancer|Squamous Cell Carcinoma

Phase 1: Dermatitis, Atopic|Dermatitis, Allergic Contact|Dermatitis, Contact

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
A-BR-104-105

P2

Completed

Esophageal Cancer|Squamous Cell Carcinoma

2017-12-01

PRURITUS- Nimpa Study

P1

Completed

Dermatitis, Contact|Dermatitis, Atopic|Dermatitis, Allergic Contact

2012-05-01

Recent News Events

Date

Type

Title

02/01/2024

PubMed

 Cream versus ointment: Randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate.

01/01/2023

PubMed

 [A CASE OF ANAPHYLAXIS INDUCED BY VITAMIN B1 DERIVATIVE IN VITAMIN B INFUSION FORMULATION FOR INTRAVENOUS INJECTION].

08/01/2022

PubMed

 Fitting Pharmacodynamic Data to the Emax Model to Assess the Inherent Potency of Topical Corticosteroids.

06/20/2019

News Article

 Fursultiamine (CAS 804-30-8) Market Research Report 2019 - ResearchAndMarkets.com

06/20/2019

News Article

 Global Fursultiamine (CAS 804-30-8) Markets 2019 - Applications, Manufacturing Methods, Patents, Prices, End-Users

06/20/2019

News Article

 Global Fursultiamine (CAS 804-30-8) Markets 2019 - Applications, Manufacturing Methods, Patents, Prices, End-Users

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions